Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices
Copenhagen, Denmark, December 14, 2022 – Brain+ A/S (Nasdaq First North: BRAINP)
· Having a standardized Quality Management System in place is a key requirement for the development and commercialization of compliant digital therapeutics · Meeting this milestone supports the company’s objective to attract large pharma partnerships and ensure product reimbursement at scaleBrain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards to ensure stringent processes throughout every step of a medical